New hope for pancreatic cancer: testing aggressive drug combo
NCT ID NCT04753879
Summary
This study is testing whether a combination of low-dose chemotherapy drugs followed by two maintenance medications can help control advanced pancreatic cancer that has spread. The trial is for adults with newly diagnosed metastatic pancreatic cancer who haven't received any prior cancer treatment. Researchers want to see if this approach can keep the cancer from progressing while managing side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sidney Kimmel Comprehensive Cancer Center
RECRUITINGBaltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.